Literature DB >> 20624075

Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice.

Kaori Sango1, Aviva Joseph, Mahesh Patel, Kristin Osiecki, Monica Dutta, Harris Goldstein.   

Abstract

Humanized Rag2(-/-)gamma(c)(-/-) mice (Hu-DKO mice) become populated with functional human T cells, B cells, and dendritic cells following transplantation with human hematopoietic stem cells (HSC) and represent an improved model for studying HIV infection in vivo. In the current study we demonstrated that intrasplenic inoculation of hu-DKO mice with HIV-1 initiated a higher level of HIV infection than intravenous or intraperitoneal inoculation, associated with a reciprocal decrease in peripheral CD4(+) T cells and increase in peripheral CD8(+) T cells. HIV infection by intrasplenic injection increased serum levels of human IgG and IgM including human IgM and IgG specific for HIV-1 gp120. There was a significant inverse correlation between the level of HIV-1 infection and the extent of CD4(+) T cell depletion. Highly active antiretroviral therapy (HAART) initiated 1 week after HIV-1 inoculation markedly suppressed HIV-1 infection and prevented CD4(+) T cell depletion. Taken together, these findings demonstrate that intrasplenic injection of hu-DKO mice with HIV is a more efficient route of HIV infection than intravenous or intraperitoneal injection and generates increased infection associated with an increased anti-HIV humoral response. This animal model can serve as a valuable in vivo model to study the efficacy of anti-HIV therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624075      PMCID: PMC2932557          DOI: 10.1089/aid.2009.0136

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  50 in total

1.  Animal models of HIV-1 disease.

Authors:  J M McCune
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

2.  Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.

Authors:  L S Klavinskis; L A Bergmeier; L Gao; E Mitchell; R G Ward; G Layton; R Brookes; N J Meyers; T Lehner
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

3.  A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.

Authors:  M L Collins; B Irvine; D Tyner; E Fine; C Zayati; C Chang; T Horn; D Ahle; J Detmer; L P Shen; J Kolberg; S Bushnell; M S Urdea; D D Ho
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

Review 4.  Human T-and B-cell functions in SCID-hu mice.

Authors:  M G Roncarolo; J M Carballido; M Rouleau; R Namikawa; J E de Vries
Journal:  Semin Immunol       Date:  1996-08       Impact factor: 11.130

5.  Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.

Authors:  Santhi Gorantla; Hannah Sneller; Lisa Walters; John G Sharp; Samuel J Pirruccello; John T West; Charles Wood; Stephen Dewhurst; Howard E Gendelman; Larisa Poluektova
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection.

Authors:  J Browning; J W Horner; M Pettoello-Mantovani; C Raker; S Yurasov; R A DePinho; H Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

8.  Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

Authors:  R M Gulick; J W Mellors; D Havlir; J J Eron; C Gonzalez; D McMahon; D D Richman; F T Valentine; L Jonas; A Meibohm; E A Emini; J A Chodakewitz
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

9.  Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells.

Authors:  S Garcia; G Dadaglio; M L Gougeon
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

10.  Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells.

Authors:  Ramon Gimeno; Kees Weijer; Arie Voordouw; Christel H Uittenbogaart; Nicolas Legrand; Nuno L Alves; Erwin Wijnands; Bianca Blom; Hergen Spits
Journal:  Blood       Date:  2004-08-19       Impact factor: 22.113

View more
  20 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion.

Authors:  Nicolas Legrand; Gisela J van der Velden; Raphaël Ho Tsong Fang; Marc Douaisi; Kees Weijer; Atze T Das; Bianca Blom; Christel H Uittenbogaart; Ben Berkhout; Mireille Centlivre
Journal:  J Gen Virol       Date:  2012-05-30       Impact factor: 3.891

3.  In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.

Authors:  Kieran Seay; Candice Church; Jian Hua Zheng; Kathryn Deneroff; Christina Ochsenbauer; John C Kappes; Bai Liu; Emily K Jeng; Hing C Wong; Harris Goldstein
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 4.  Humoral immunity in humanized mice: a work in progress.

Authors:  Edward Seung; Andrew M Tager
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

Review 5.  New generation humanized mice for virus research: comparative aspects and future prospects.

Authors:  Ramesh Akkina
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

Review 6.  Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Authors:  LiGuo Zhang; Eric Meissner; JianZhu Chen; LiShan Su
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

Review 7.  Humanized mouse models of HIV infection.

Authors:  Paul W Denton; J Víctor García
Journal:  AIDS Rev       Date:  2011 Jul-Sep       Impact factor: 2.500

Review 8.  Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders?

Authors:  Santhi Gorantla; Howard E Gendelman; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-07       Impact factor: 4.147

9.  A Simple Mouse Model for the Study of Human Immunodeficiency Virus.

Authors:  Kang Chang Kim; Byeong-Sun Choi; Kyung-Chang Kim; Ki Hoon Park; Hee Jung Lee; Young Keol Cho; Sang Il Kim; Sung Soon Kim; Yu-Kyoung Oh; Young Bong Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2015-12-17       Impact factor: 2.205

10.  Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouse.

Authors:  Shailesh K Choudhary; Nancie M Archin; Manzoor Cheema; Noelle P Dahl; J Victor Garcia; David M Margolis
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.